Health Economics in Radiation Oncology: Introducing the ESTRO HERO project

Radiotherapy and Oncology

Volumn 103, Issue 1, 2012, Pages 109-112

  Lievens, Yolande ^a   Grau, Cai ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Accessibility; Cost calculation; Economic evaluation; Infrastructure; Radiotherapy; Staffing

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; EUROPE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; PATIENT SAFETY; PRIORITY JOURNAL; TECHNOLOGY;

COST-BENEFIT ANALYSIS; EUROPE; HEALTH CARE COSTS; HUMANS; NEOPLASMS; RADIATION ONCOLOGY; SOCIETIES, MEDICAL;

EID: 84859725583     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.12.026     Document Type: Article

References (29)

1. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92. (Pubitemid 46359643)
2. Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-83. (Pubitemid 47321600)
3. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden and the UK, 1995-2007 (the international Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127-38.
4. SBU. The Swedish council on technology assessment in health care: radiotherapy for cancer. Acta Oncol 1996;1:35.
5. Korreman S, Rasch C, McNair H, et al. The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide. Radiother Oncol 2010;94:129-44.
6. Chi A, Liao Z, Nguyen Nam P, et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 2010;94:1-11.
7. Kopek N, Paludan M, Petersen J, et al. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage nonsmall cell lung cancer. Radiother Oncol 2009;93:401-7.
8. Kopek N, Holt MI, Hansen AT, Hoyer M. Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 2010;94:47-52.
9. Dimopoulos Johannes CA, Richard Pötter, Stefan Lang, et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 2009;93:311-5.
10. 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints. Radiother Oncol 2010;94:339-45.
11. Troost EGC, Schinagl DAX, Bussink J, et al. Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours. Radiother Oncol 2010;96:328-34.
12. Amelio D, Lorentini S, Schwarz M, et al. Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues. Radiother Oncol 2010;97:361-9.
13. Scott-Brown M, Miah A, Harrington K, et al. Evidence-based review: quality of life following head and neck intensity-modulated radiotherapy. Radiother Oncol 2010;97:249-57.
14. Delaney GP, Jacob S, Featherstone C, Barton MB. The role of radiotherapy in cancer care: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005;104:1129-37. (Pubitemid 41278947)
15. Williams MV, Drinkwater KJ. Geographical variation in radiotherapy services across the UK in 2007 and the effect of deprivation. Clin Oncol 2009;21:431-40.
16. Barton M, Frommer M, Shafiq J. Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol 2006;7:584-95. (Pubitemid 43923676)
17. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65. (Pubitemid 29493800)
18. Lievens Y, Kesteloot K, Rijnders A, et al. Differences in palliative radiotherapy for bone metastases within western European countries. Radiother Oncol 2000;56:297-303.
19. Fairchild A, Barnes E, Ghosh S, et al. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice? Int J Radiat Oncol Biol Phys 2009;75:1501-10.
20. Sharma V, Gaye PM, Wahab SA, et al. Patterns of practice of palliative radiotherapy in Africa. Part 1: Bone and brain metastases? Int J Radiat Oncol Biol Phys 2008;70:1195-201. (Pubitemid 351308064)
21. Casas F, Vinolas N, Sanchez-Reyes A, et al. Spanish patterns of care for 3D radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;65:138-42.
22. Kepka L, Danilova V, Saghatelyan T, et al. Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey. Lung Cancer 2007;56:235-45. (Pubitemid 46591989)
23. Granados A, Jonsson E, Banta HD. EUR-assess project subgroup report on dissemination and impact. Int J Technol Assess Health Care 1997;13:220-86. (Pubitemid 27214832)
24. Williams MV, Summers ET, Drinkwater K, Barrett A. Radiotherapy dose fractionation, access and waiting times in the countries of the UK in 2005. Clin Oncol 2007;19:273-85.
25. Bentzen S, Heeren G, Cottier B, et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol 2005;75:355-65. (Pubitemid 41007983)
26. Kesteloot K, Pocceschi S, van der Schueren E. Reimbursement for radiotherapy treatment in the EU countries: how to encourage efficiency, quality and access? Radiother Oncol 1996;38:187-94. (Pubitemid 26079433)
27. Aas IHM. Incentives and financing methods. Health Policy 1995;34: 205-20.
28. Lievens Y, Van den Bogaert W, Rijnders A, et al. Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system? Radiot Oncol 2000;56:289-95.
29. Slotman B, Cottier B, Bentzen S, et al. Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1. Radiother Oncol 2005;75:349-54.